Skip to content

antidepressants-healthinequalities

Organisation:
NHSE/I
Project:
Antidepressants

Job information

Repo
antidepressants

This repo is not publicly viewable.

Why is this repo private?

In accordance with the Principles of OpenSAFELY we expect all code from all users to be made public.

However, some GitHub repositories may be private during the development stage of a project, which means any links to them from this site will return a '404 Not Found' error unless you are logged in and have the relevant permissions.

Branch
main
Database
full
Created
Created by
Nisha Rajendran

This is an OpenSAFELY workspace. It represents a working directory for the Antidepressants project on all of the secure services ("backends") supported by OpenSAFELY.

On each backend, the directory includes code from the repository, and the results of running it against real data ("jobs"). Researchers can request jobs are run from this page.

Workspace purpose

Following on from the commissioned Public Health England (PHE) Review on dependency forming medicines, NHSE&I is leading on implementation of the recommendations as published in the report with the following aims: i) the optimisation of medicines that can cause dependence and withdrawal and ensure they are prescribed and reviewed in line with evidence-based guidance; ii) patients taking medicines that can cause dependence and withdrawal in the most clinically effective and safest way possible; iii) the availability of appropriate services to deliver the best patient outcomes for populations; and iv) focused on increasing the availability and use of data including routine publishing and development of metrics highlighting variation and uptake of alternative interventions and support services; risk stratification and identifying need; consistent and coordinated publication with easy access for all users and purposes; access to data, transparency of methodology and code for third party use. To ensure implementation decisions are made on an equitable basis to improve health outcomes and the experiences of all patients, communities and the workforce, other key information is essential to highlight, prioritise and address health inequalities as well as assess the impact of COVID-19 on the prescribing of these medicines. We will investigate the impact of COVID-19 on dependency forming medication use by age, gender, Index of Multiple Deprivation (IMD), ethnicity, region. Insight will help inform more immediate programme implementation measures, support pandemic research and co-ordinate the ongoing national response in alignment with the overall programme.